Molecular biomarkers of thyroid follicular tumor

Jin-hua XIONG,Jian WANG
DOI: https://doi.org/10.3760/cma.j.issn.1673-4157.2011.06.018
2011-01-01
International Journal of Endocrinology and Metabolism
Abstract:Benign and malignant thyroid nodules are mainly differentiated by ultrasound examination,radioactive scanning,and fine-needle aspiration biopsy (FNAB).FNAB is more accurate in the diagnosis of papillary thyroid carcinoma and thyroid carcinoma.However,it is less accurate in the diagnosis of hyperplastic nodule,follicular adenoma,follicular carcinoma,and follicular variant papillary carcinoma called "follicular neoplasms" or "suspicious or follicular-pattemedn lesion".Recent research has showed that some protein molecular can be used as markers to identify between benign and malignant thyroid tumors,because they are expressed differently on genes of thyroid follicular tumors.These molecular markers include DNA damage inducible transcript 3 ( DDIT3 ),arginase Ⅱ ( ARG2 ),chromosome 1 open reading frame 24 (Clorf24),integral membrane protein 1 ( ITM1 ),Ras,Nuclear receptor subfamily 4,group A,member 1 ( N R4A1 ),highmobility group A2 ( HMGA2 ),NESH-SH3 binding protein ( TARSH ),decorin ( DCN ),phosphatase and tensin homolog deleted on chromosome ten ( PTEN ).
What problem does this paper attempt to address?